Cme (CME) Capital Expenditures (2010 - 2026)

Cme (CME) has 17 years of Capital Expenditures data on file, last reported at $21.8 million in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $21.8 million, up 53.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $91.1 million (up 3.05% YoY), and the FY2025 annual result was $83.5 million, down 11.17% from the prior year.
• Capital Expenditures declined to $21.8 million in Q1 2026 per CME's latest filing, from $32.5 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $32.5 million in Q4 2025 and troughed at $14.2 million in Q1 2025.
• A 5-year average of $21.5 million and a median of $20.5 million in 2023 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2022 and 2026: Capital Expenditures plunged 54.91% in 2022, then surged 53.52% in 2026.
• A 5-year view of Capital Expenditures shows it stood at $24.4 million in 2022, then decreased by 14.75% to $20.8 million in 2023, then climbed by 25.96% to $26.2 million in 2024, then gained by 24.05% to $32.5 million in 2025, then tumbled by 32.92% to $21.8 million in 2026.
• Business Quant data shows CME's Capital Expenditures at $21.8 million in Q1 2026, $32.5 million in Q4 2025, and $18.4 million in Q3 2025.